© The Financial Times Ltd 2014 FT and 'Financial Times' are trademarks of The Financial Times Ltd.
As of Apr 18, 2014, the consensus forecast amongst 19 polled investment analysts covering PT Kalbe Farma Tbk advises that the company will outperform the market. This has been the consensus forecast since the sentiment of investment analysts improved on Dec 07, 2012. The previous consensus forecast advised investors to hold their position in PT Kalbe Farma Tbk.
|Last year||3 months ago||2 months ago||4 weeks ago||Latest|
The 13 analysts offering 12 month price targets for
Historical dividend information is not available for
|Div growth (TTM)||+35.71%|
On Oct 29, 2013,
The next earnings announcement is expected on Apr 28, 2014. View Full Interim Financials
|Average growth rate||+88.70%|
|Average growth rate||+21.08%|
PT Kalbe Farma Tbk had 4th quarter 2013 revenues of 4.56bn. This missed the 4.60bn consensus estimate of the 7 analysts following the company. This was 13.53% above the prior year's 4th quarter results. View Full Interim Financials
|Average growth rate||+4.23%|
PT Kalbe Farma Tbk had revenues for the full year 2013 of 16.00bn. This was 17.35% above the prior year's results. View Full Annual Financials
|Average growth rate||+15.48%|